Comparison of MwPharm 3.30 (DOS) and MwPharm plus plus (Windows) Versions of Pharmacokinetic Software for PK/PD Monitoring of Vancomycin for dialyzed patients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F22%3AA2302G75" target="_blank" >RIV/61988987:17110/22:A2302G75 - isvavai.cz</a>
Result on the web
<a href="https://www.webofscience.com/wos/woscc/full-record/WOS:000815076100285" target="_blank" >https://www.webofscience.com/wos/woscc/full-record/WOS:000815076100285</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Comparison of MwPharm 3.30 (DOS) and MwPharm plus plus (Windows) Versions of Pharmacokinetic Software for PK/PD Monitoring of Vancomycin for dialyzed patients
Original language description
Introduction: For a long time, the MwPharm software suite (MEDIWARE, Prague, Czech Republic / Groningen, Netherlands) has been used for PK/PD modelling in therapeutic drug monitoring (TDM). Objective: The aim of this study was to find the best model in the newer Windows version of MwPharm++ 1.3.5.558 (WIN) for patient on intermittent hemodialysis. Methods: Twenty-two adult patients with mean age 65±15 years, body weight 88±25 kg, were repeatedly examined for vancomycin. Cmin and concentration before hemodialysis (CBH) predicted by Windows models “vancomycin_dialysis_c2 “ (WINd), ”vancomycin_adult_C2“ (WINa), and DOS 3.30 models ” vancomycin (dialysis)“ (DOSd), ”vancomycin adult“ (DOSa) were compared with the with the measured value and with DOSd model. Statistics: Percentage prediction error (%PE) calculated as (predicted–measured)/measured or (predicted-DOSd)/DOSd, RMSE, Blandt-Altman bias, Pearson’s coefficient of rank correlation (R), Student’s t-test. Statistical analysis was performed using GraphPad Prism version 5.00 for Windows. Results: Models WINd and DOSd produced better Cmin prediction then respective adult models. DOSd model produced lower %PE, BlandtAltman bias and Pearson R, while slightly higher RMSE than WINd model. CBH prediction (available only in 7 cases) was better by WINa compared to WINd, while similar by DOSa and DOSd (Table 1). WINd and DOSd models use higher population V1 and Clm while lower fr than WINa and DOSa models (Table 2). V1, k12 were higher, while k21 was lower in all models than respective population data. Clm was higher in DOSa, while lower in WINa and fixed in WINd. Fr was lower in WINa and DOSa. Conclusion: DOS and WIN models are not identical despite similar name and the same population data. Dialysed models should be use for TDM in dialysed patients. DOSd model produced the best prediction while WINd was poorer. Implementation of DOSd model into WIN version of MWPharm is recommended.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
The Abstracts
ISBN
—
ISSN
0031-6970
e-ISSN
—
Number of pages
1
Pages from-to
138-138
Publisher name
SPRINGER HEIDELBERG
Place of publication
—
Event location
Atény
Event date
Jun 25, 2022
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
000815076100285